相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment
Zachary A. Marcum et al.
JAMA NETWORK OPEN (2022)
The renin-angiotensin system and the brain
M. Molina-Van den Bosch et al.
HIPERTENSION Y RIESGO VASCULAR (2021)
Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial
Patrick Gavin Kehoe et al.
LANCET NEUROLOGY (2021)
The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer's disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status
Michael Ouk et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Associations between brain amyloid accumulation and the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers
Michael Ouk et al.
NEUROBIOLOGY OF AGING (2021)
Transcriptomic Analysis of Mouse Brain After Traumatic Brain Injury Reveals That the Angiotensin Receptor Blocker Candesartan Acts Through Novel Pathways
Peter J. Attilio et al.
FRONTIERS IN NEUROSCIENCE (2021)
NeuroMark: An automated and adaptive ICA based pipeline to identify reproducible fMRI markers of brain disorders
Yuhui Du et al.
NEUROIMAGE-CLINICAL (2020)
Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment A Randomized Clinical Trial
Ihab Hajjar et al.
JAMA NETWORK OPEN (2020)
Cerebrospinal Fluid Changes in the Renin-Angiotensin System in Alzheimer's Disease
Patrick G. Kehoe et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment?
Patrick Gavin Kehoe
JOURNAL OF ALZHEIMERS DISEASE (2018)
Angiotensin receptor blocker, losartan ameliorates neuroinflammation and behavioral consequences of lipopolysaccharide injection
Hossein Salmani et al.
LIFE SCIENCES (2018)
Angiotensin-III is Increased in Alzheimer's Disease in Association with Amyloid-β and Tau Pathology
Patrick Gavin Kehoe et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Association between blood pressure and Alzheimer disease measured up to 27 years prior to diagnosis: the HUNT Study
Jessica Mira Gabin et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Angiotensin-(1-7) is Reduced and Inversely Correlates with Tau Hyperphosphorylation in Animal Models of Alzheimer's Disease
Teng Jiang et al.
MOLECULAR NEUROBIOLOGY (2016)
The association of renin-angiotensin system blockade use with the risks of cognitive impairment of aging and Alzheimer's disease: A meta-analysis
Shan Zhuang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2016)
An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer's disease
Abdel G. Elkahloun et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Association Between Angiotensin Receptor Blockers and Longitudinal Decline in Tau in Mild Cognitive Impairment
Ihab Hajjar et al.
JAMA NEUROLOGY (2015)
Candesartan Improves Ischemia-Induced Impairment of the Blood-Brain Barrier In Vitro
Gohei So et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2015)
Special Series Introduction: NIH EXAMINER and the Assessment of Executive Functioning
Joel H. Kramer
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2014)
[18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease
Chun-Fang Xia et al.
ALZHEIMERS & DEMENTIA (2013)
Angiotensin (1-7) and other Angiotensin Peptides
Mitsuru Ohishi et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Antihypertensive Therapy and Cerebral Hemodynamics in Executive Mild Cognitive Impairment: Results of a Pilot Randomized Clinical Trial
Ihab Hajar et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2013)
Effect of Antihypertensive Therapy on Cognitive Function in Early Executive Cognitive Impairment: A Double-blind Randomized Clinical Trial
Ihab Hajjar et al.
ARCHIVES OF INTERNAL MEDICINE (2012)
Candesartan, an Angiotensin II AT1-Receptor Blocker and PPAR-γ Agonist, Reduces Lesion Volume and Improves Motor and Memory Function After Traumatic Brain Injury in Mice
Sonia Villapol et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Symmetric geometric transfer matrix partial volume correction for PET imaging: principle, validation and robustness
Mike Sattarivand et al.
PHYSICS IN MEDICINE AND BIOLOGY (2012)
Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage
Masatsugu Horiuchi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Validation of the New Interpretive Guidelines for the Clinical Dementia Rating Scale Sum of Boxes Score in the National Alzheimer's Coordinating Center Database
Sid E. O’Bryant et al.
ARCHIVES OF NEUROLOGY (2010)
Direct Angiotensin II Type 2 Receptor Stimulation Acts Anti-Inflammatory Through Epoxyeicosatrienoic Acid and Inhibition of Nuclear Factor κB
Franziska Rompe et al.
HYPERTENSION (2010)
Alzheimer's Disease Neuroimaging Initiative (ADNI) Clinical characterization
R. C. Petersen et al.
NEUROLOGY (2010)
Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects
Leslie M. Shaw et al.
ANNALS OF NEUROLOGY (2009)
Anti-Inflammatory Effects of Angiotensin Receptor Blockers in the Brain and the Periphery
Julius Benicky et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2009)
The renin-angiotensin systems: Evolving pharmacological perspectives for cerebroprotection
L Magy et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Recommendations for blood pressure measurement in humans and experimental animals - Part 1: Blood pressure measurement in humans - A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research
TG Pickering et al.
HYPERTENSION (2005)
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
WE Klunk et al.
ANNALS OF NEUROLOGY (2004)
Is the angiotensin II type 2 receptor cerebroprotective?
A Fournier et al.
CURRENT HYPERTENSION REPORTS (2004)
Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo:: role of the AT2 receptor and the transcription factor NF-κB
K Reinecke et al.
FASEB JOURNAL (2003)
Psychometrically matched measures of global cognition, memory, and executive function for assessment of cognitive decline in older persons
D Mungas et al.
NEUROPSYCHOLOGY (2003)
The brain renin-angiotensin system: location and physiological roles
MJ McKinley et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2003)
Memory and motor skill components of the WAIS-III Digit Symbol-Coding subtest
DS Kreiner et al.
CLINICAL NEUROPSYCHOLOGIST (2001)